UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 20, 2014
CANNAPHARMARX, INC.
---------------------
(Exact name of Registrant as specified in its charter)
Delaware 000-27055 24-4635140
---------------------------- ----------------------- -----------------------
(State or other jurisdiction (Commission File Number (IRS Employer Identifi-
of incorporation) cation No.)
One Collins Drive, Salem Business Center, Carneys Point, NJ 08069-3640
--------------------------------------------------
(Address of principal executive offices)
720-939-1133
-----------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
-----------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
SECTION 8 - OTHER EVENTS
Item 8.01 Other Events
The Company has been notified it has been joined in a lawsuit by a director,
Gary Cohen. The Company's subsidiary, CannaPharmRx, Inc., a Colorado
corporation, is also named in the lawsuit. The lawsuit was filed in the Circuit
Court of the Thirteenth Judicial District in and for Hillsborough County,
Florida under Case Number 14-CA-010970 in Division T.
The Company intends to vigorously defend itself and has filed a lawsuit for
defamation and tortious interference with business relationships against Gary
Cohen in Federal Court in New Jersey regarding Mr. Cohen's libelous statements
and efforts to unlawfully interfere with and harm the Company.
The Company's position is that his claims are spurious and ill-founded, and it
will continue to defend and countersue Cohen for numerous claims of its own.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CANNAPHARMRARX, INC.
Formerly Golden Dragon Holding Co.
By: /s/ Gerry Crocker
---------------------------------------
Chief Executive Officer
Date: November 21, 2014
